CRISPR Tx cuts cancer programs, expands into autoimmune disease – Fierce Biotech
Days away from an FDA decision on a sickle cell gene therapy, CRISPR Therapeutics is ditching its “first-generation” allogeneic CAR-T candidates.
» Read moreDays away from an FDA decision on a sickle cell gene therapy, CRISPR Therapeutics is ditching its “first-generation” allogeneic CAR-T candidates.
» Read moreA recent study in the British Journal of Sports Medicine reveals that brisk walking significantly reduces the risk of type 2 diabetes.
» Read moreThe data backs this up: women are more likely to use alternative medicine, often driven by a negative experience with the Western health system – or …
» Read more… chronic obstructive pulmonary disease (COPD) prognosis. They also compared the models with previous predictive regression models. Study: Machine …
» Read moreTreadmills offer versatile workout options, allowing users to control speed, incline, and intensity. Regular treadmill workouts help with weight …
» Read morePrime Minister Anthony Albanese confirmed Peta Murphy’s death at a press conference in Canberra today.
» Read moreThe Diabetes Management report provides a study with an in-depth overview, describing the product/industry scope and elaborates market outlook and …
» Read moreReport Ocean has recently released the newest industry analysis focusing on “Saudi Arabia Herbal Medicine Market”.
» Read moreCOPD; Allergic Rhinitis; Pulmonary Arterial Hypertension; Others. By Patient Type: Adult; Pediatric. By Dosage Form: Capsules; Solution; Suspension …
» Read moreCardiac beriberi, also known as wet beriberi, is a severe manifestation of thiamine (vitamin B1) deficiency that affects the cardiovascular system …
» Read moreDiscover the myriad benefits of regular physical activity, from boosting energy levels to enhancing mood. Explore the positive impact on heart …
» Read moreBrogan Williams, a nurse at New Cross Hospital, Wolverhampton, died from breast cancer in October aged 35. The mum of one had raised £5,000 for …
» Read more